Written by Jessica McDermott, MD Introduction Anyone who currently has or who has survived head and neck squamous cell cancer (HNSCC) can tell you that the cancer itself and the treatment involved can cause significant pain. The location of the tumors as...
Richard C. Niemtzow, MD, PhD, MPH Xerostomia Xerostomia or dry mouth is caused by a disturbance of the salivary glands. This is especially prevalent among head and neck oncology patients who have experienced chemotherapy, radiation and surgery for their head and neck...
Dan Zandberg, MD Introduction Currently, two immunotherapy medications, Nivolumab (Opdivo) and Pembrolizumab (Keytruda) are approved in the USA for recurrent and or metastatic squamous cell carcinoma of head and neck (HNSCC) after a patient received and failed “platinum” based chemotherapy. Both Nivolumab...
Robert L. Ferris, MD, PhD Clinical trials are a key research tool for advancing medical knowledge and patient care. Clinical research is done only if doctors do not know whether a new approach works well in people and is safe and...
Liza Murray, APRN & Allen M. Chen, MD What is cancer survivorship? Survivorship focuses on the health and life of a person with cancer from initiation of treatment until the end of life. It covers the physical, psychosocial and economic issues of...
